4th Quarter - Report
AGIOS PHARMACEUTICALS for AGIOS PHARMACEUTICALS
Client
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Sickle Cell policy Biotech innovation
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON KRUPP | — |
Medical/Disease Research/Clinical Labs MED
Biotech Innovation
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON KRUPP | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.